FOI release

Statut of Northwest Biotherapeutics MAA submitted in Decembre 2023

This request was refused in full, so we didn't provide the information the requester asked for. This may include information where we can neither confirm nor deny that we hold it.

Case reference FOI2026/00848

Received 31 July 2026

Published 17 September 2026

Request

I formally inquire about the regulatory review status of the Marketing Authorization Application (MAA) for DCVax-L (autologous tumor lysate-loaded dendritic cell vaccination), submitted by Northwest Biotherapeutics in December 2023.

Response

See attached

Documents

• FOI2026_00848 (redacted).pdf (940.8 KB)

This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.